Technical Analysis for NVCN - Neovasc Inc.

Grade Last Price % Change Price Change
grade F 0.4588 -2.78% -0.01
NVCN closed down 2.78 percent on Tuesday, March 19, 2019, on 81 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical NVCN trend table...

Date Alert Name Type % Chg
Mar 19 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Mar 19 Narrow Range Bar Range Contraction 0.00%
Mar 19 NR7 Range Contraction 0.00%
Mar 19 Inside Day Range Contraction 0.00%
Mar 19 Wide Bands Range Expansion 0.00%
Mar 19 Oversold Stochastic Weakness 0.00%
Mar 18 Narrow Range Bar Range Contraction -2.78%
Mar 18 Wide Bands Range Expansion -2.78%
Mar 18 Oversold Stochastic Weakness -2.78%
Mar 15 Narrow Range Bar Range Contraction -0.35%

Older signals for NVCN ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets cardiovascular products worldwide. Its products include the Neovasc Reducer for the treatment of refractory angina; and Tiara technology in development for the transcatheter treatment of mitral valve disease. The company also develops and manufactures the PeriPatch, a line of biological tissue products for use in third-party medical products, including transcatheter heart valves. In addition, the company provides a range of custom Peripatch products to industry customers for incorporation into their own products; and consulting and original equipment manufacturing services to other medical device companies. Further, it offers pericardial tissue processing, vascular product development, design, and manufacturing solutions to industry partners. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.
Medicine Medical Specialties Medical Devices Circulatory System Interventional Cardiology Cardiac Surgery Cardiovascular Products Cardiovascular Edwards Lifesciences Heart Valve Valvular Heart Disease
Is NVCN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 12.5
52 Week Low 0.42
Average Volume 1,897,794
200-Day Moving Average 2.1104
50-Day Moving Average 0.6262
20-Day Moving Average 0.5256
10-Day Moving Average 0.4934
Average True Range 0.0557
ADX 13.16
+DI 21.3918
-DI 21.9964
Chandelier Exit (Long, 3 ATRs ) 0.5329
Chandelier Exit (Short, 3 ATRs ) 0.5871
Upper Bollinger Band 0.6665
Lower Bollinger Band 0.3847
Percent B (%b) 0.26
BandWidth 53.614916
MACD Line -0.052
MACD Signal Line -0.0506
MACD Histogram -0.0014
Fundamentals Value
Market Cap 36.2 Million
Num Shares 78.9 Million
EPS -0.07
Price-to-Earnings (P/E) Ratio -6.55
Price-to-Sales 13.79
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.49
Resistance 3 (R3) 0.49 0.48 0.48
Resistance 2 (R2) 0.48 0.47 0.48 0.48
Resistance 1 (R1) 0.47 0.47 0.47 0.47 0.48
Pivot Point 0.46 0.46 0.46 0.46 0.46
Support 1 (S1) 0.45 0.46 0.45 0.45 0.44
Support 2 (S2) 0.45 0.45 0.45 0.44
Support 3 (S3) 0.44 0.45 0.44
Support 4 (S4) 0.43